Popular Stories

Lung Cancer Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
6 Reasons Why Replimune Offers Huge Growth Potential!

Replimune group, Inc. (NASDAQ: REPL) is leveraging the power of its proprietary Immulytic platform to create a leading-edge oncolytic immunotherapy program that can generate a patient-specific local as well as systemic immune response. The therapies not only fight against the current cancer but also eliminate...

Sorrento could be the next breakout stock. Find out why!

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is in the spotlight after receiving a “Buy” rating along with a $30 price target from Ram Selvaraju an analyst at H.C Wainwright, implying a nearly 275% upside from its current levels. We take a look at reasons for the...

Pulmatrix Soars on News of Licensing Agreement with Johnson & Johnson

Pulmatrix Inc (NASDAQ: PULM), a Clinical Stage Biopharmaceutical Company developing inhaled therapies for the treatment of pulmonary diseases, announced the signing of a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson (NYSE: JNJ), enabling the initiative to access the Company’s...

Artificial Intelligence Spearheading the Fight against Cancer

Artificial Intelligence is making inroads into every segment of the economy including medicine and surgery. Intuitive Surgical Inc. (NASDAQ:ISRG), the market leader in robotic surgery, commands $3.3 billion in annual sales, and the numbers are going to increase manifold in the near future. Companies like...

WordPress Video Lightbox Plugin